Management of Acute Gastric Pain
For acute gastric pain, initiate full-dose proton pump inhibitor therapy (omeprazole 20-40 mg once daily or equivalent) as first-line treatment, which provides superior symptom relief and healing compared to H2-receptor antagonists or placebo. 1, 2
Initial Assessment and Red Flag Identification
Before initiating empirical therapy, identify patients requiring urgent endoscopy:
- Age >50 years (or lower threshold based on local gastric cancer incidence) 1
- Alarm symptoms: dysphagia, persistent vomiting, weight loss, evidence of bleeding, anemia, or palpable mass 1
- Regular NSAID use: refer directly for endoscopy 1
- Hemodynamic instability: requires immediate resuscitation and urgent endoscopy 1, 2
First-Line Pharmacologic Management
Proton pump inhibitors are the treatment of choice for acute gastric pain:
- Omeprazole 20-40 mg once daily is the standard dose, with higher doses (40 mg) showing superior healing rates at 4 weeks compared to ranitidine 3, 4, 5
- Alternative PPIs: lansoprazole 30 mg, pantoprazole 40 mg, or rabeprazole 20 mg daily are equally effective 3, 5
- Duration: Continue for 4-8 weeks for gastric ulcers (longer than duodenal ulcers) 3, 2
- Superiority over H2-blockers: PPIs achieve 67% healing at 4 weeks versus 37% with H2-receptor antagonists, and 81% versus 49% at 8 weeks 6
Common pitfall: Using H2-receptor antagonists instead of PPIs results in inferior healing rates and slower symptom relief 2, 5
Symptom-Based Treatment Algorithm
For epigastric pain (ulcer-like dyspepsia):
- Start full-dose PPI therapy immediately 1
- Response to therapy confirms acid-related nature of symptoms 1
- This approach is consistent with GORD treatment guidelines 1
For symptoms <4 weeks duration without alarm features:
- Reassurance and over-the-counter antacids may be appropriate initially 1
- However, if pain is moderate to severe, proceed directly to PPI therapy 1
H. pylori Testing Strategy
In low-risk patients with symptoms ≥4 weeks:
- Test for H. pylori using urea breath test or stool antigen 1, 2
- If positive, eradicate with triple therapy (PPI + 2 antibiotics for 7-14 days) 2, 3
- Critical: Confirm eradication after treatment 2
- Important caveat: Many patients will have persistent dyspeptic symptoms after successful eradication, but peptic ulcer mortality risk is eliminated 1
Common pitfall: Failing to test for H. pylori in all gastric ulcer patients delays definitive management 2
When Endoscopy is Mandatory
Proceed to endoscopy if:
- Alarm symptoms present at any age 1, 2
- Age >50 years (adjust based on local gastric cancer incidence) 1
- Symptoms persist after 4-8 weeks of PPI therapy 1
- Regular NSAID use 1
- Hemodynamic instability or evidence of bleeding 1, 2
During endoscopy: Multiple biopsies from ulcer margins and base are mandatory to exclude malignancy, as gastric ulcers cannot be reliably distinguished as benign by appearance alone 2
Management of Bleeding Gastric Ulcers
For hemodynamically stable patients:
- Early endoscopic evaluation is first-line for diagnosis and treatment 1
- Dual modality endoscopic hemostasis is recommended 2
- Maintain hemoglobin >7 g/dL, target systolic BP 90-100 mmHg 2
- Continue PPI therapy for 6-8 weeks post-endoscopic treatment 2
For refractory bleeding:
- Repeat endoscopy is first-line for recurrent bleeding 2
- Transcatheter angioembolization if endoscopy fails or is unavailable 1, 2
- Surgical hemostasis for ulcers >2 cm with recurrent bleeding 1
Common pitfall: Performing angiography before endoscopy results in unacceptable rates of negative investigations 2
NSAID-Related Gastric Pain
For patients requiring continued NSAID therapy:
- Omeprazole is superior to placebo and misoprostol in preventing NSAID-induced damage 7
- Continue PPI prophylaxis throughout NSAID use 2, 7
- PPIs are better tolerated than misoprostol 3
Follow-Up Requirements
All gastric ulcers require:
- Repeat endoscopy at approximately 6 weeks to confirm healing and exclude malignancy 2
- Continue PPI until healing is confirmed 2
- If H. pylori testing was negative during acute bleeding, repeat testing as bleeding causes false-negatives 2
Treatment Failure Management
If symptoms persist after initial PPI course: